CHE - Chemed Corporation Stock Analysis | Stock Taper
Logo
Chemed Corporation

CHE

Chemed Corporation NYSE
$385.77 0.30% (+1.16)

Market Cap $5.31 B
52w High $593.80
52w Low $365.21
Dividend Yield 0.51%
Frequency Quarterly
P/E 20.94
Volume 195.56K
Outstanding Shares 13.77M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q4-2025 $639.34M $105.5M $76.75M 12% $5.48 $122.3M
Q3-2025 $624.9M $105.78M $64.24M 10.28% $4.46 $101.78M
Q2-2025 $618.8M $116.61M $52.49M 8.48% $3.6 $87.82M
Q1-2025 $646.94M $121.66M $71.76M 11.09% $4.91 $112.02M
Q4-2024 $639.99M $120.24M $90.32M 14.11% $6.08 $136.45M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q4-2025 $74.52M $1.64B $660.61M $979.4M
Q3-2025 $129.75M $1.62B $546.94M $1.08B
Q2-2025 $249.9M $1.72B $519.36M $1.2B
Q1-2025 $173.88M $1.73B $544.75M $1.18B
Q4-2024 $178.35M $1.67B $549.58M $1.12B

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q4-2025 $76.75M $133.53M $-15.95M $-172.82M $-55.24M $117.19M
Q3-2025 $64.24M $83.39M $-14.23M $-189.31M $-120.15M $66.03M
Q2-2025 $52.49M $138.61M $-15.48M $-47.1M $76.02M $122.8M
Q1-2025 $71.76M $32.74M $-13.67M $-23.54M $-4.47M $19.46M
Q4-2024 $90.32M $164.91M $-12.52M $-212.49M $-60.1M $152.15M

Revenue by Products

Product Q1-2025Q2-2025Q3-2025Q4-2025
Segment Roto Rooter
Segment Roto Rooter
$250.00M $230.00M $230.00M $230.00M
Segment Vitas
Segment Vitas
$420.00M $420.00M $420.00M $430.00M

Q4 2025 Earnings Call Summary

Read Call Summary

5-Year Trend Analysis

A comprehensive look at Chemed Corporation's financial evolution and strategic trajectory over the past five years.

+ Strengths

Chemed combines strong profitability, robust cash generation, and a conservative balance sheet with leadership positions in two essential service markets. The business benefits from scale, brand strength, and operational expertise, particularly in regulated hospice care and time‑sensitive plumbing services. Liquidity and leverage are well managed, free cash flow is ample, and ongoing technology and process innovations support service quality and efficiency.

! Risks

Key risks center on regulatory and reimbursement exposure in hospice, labor cost and availability in healthcare, and the inherently fragmented, locally competitive nature of the plumbing and home services market. The balance sheet’s heavy reliance on goodwill and intangible assets introduces potential impairment risk if acquired businesses underperform. Aggressive capital returns via buybacks and dividends also reduce the cash buffer, making ongoing performance and cash generation critical.

Outlook

Based on the available information, Chemed appears positioned for steady performance, supported by defensive, needs‑based demand in hospice and recurring service needs in plumbing and restoration. Future results will likely depend on how well the company manages regulatory and labor headwinds, continues integrating technology and analytics into both businesses, and balances shareholder returns with maintaining financial flexibility. With only one year of detailed financial data, visibility into long‑term trends is limited, but the current snapshot suggests a mature, well‑run company with clear competitive advantages and manageable, though meaningful, external risks.